Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEFIBROTIDE Cause Cystitis haemorrhagic? 94 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Cystitis haemorrhagic have been filed in association with DEFIBROTIDE (DEFITELIO). This represents 2.5% of all adverse event reports for DEFIBROTIDE.

94
Reports of Cystitis haemorrhagic with DEFIBROTIDE
2.5%
of all DEFIBROTIDE reports
33
Deaths
42
Hospitalizations

How Dangerous Is Cystitis haemorrhagic From DEFIBROTIDE?

Of the 94 reports, 33 (35.1%) resulted in death, 42 (44.7%) required hospitalization, and 1 (1.1%) were considered life-threatening.

Is Cystitis haemorrhagic Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEFIBROTIDE. However, 94 reports have been filed with the FAERS database.

What Other Side Effects Does DEFIBROTIDE Cause?

Off label use (1,323) Venoocclusive disease (576) Death (463) Multiple organ dysfunction syndrome (372) Venoocclusive liver disease (355) Intentional product use issue (201) Hypotension (169) Haemorrhage (156) Sepsis (143) Acute graft versus host disease (140)

What Other Drugs Cause Cystitis haemorrhagic?

CYCLOPHOSPHAMIDE (1,036) CYCLOSPORINE (591) MYCOPHENOLATE MOFETIL (476) METHOTREXATE (413) FLUDARABINE (386) BUSULFAN (336) TACROLIMUS (336) MESNA (294) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (289) RITUXIMAB (261)

Which DEFIBROTIDE Alternatives Have Lower Cystitis haemorrhagic Risk?

DEFIBROTIDE vs DEFLAZACORT DEFIBROTIDE vs DEGARELIX DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE DEFIBROTIDE vs DELAMANID DEFIBROTIDE vs DELANDISTROGENE MOXEPARVOVEC-ROKL

Related Pages

DEFIBROTIDE Full Profile All Cystitis haemorrhagic Reports All Drugs Causing Cystitis haemorrhagic DEFIBROTIDE Demographics